| Nov 14 |
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions
|
| Nov 13 |
MindMed to Participate in Upcoming Investor Conferences
|
| Nov 10 |
Mind Medicine: No News = Good News
|
| Nov 8 |
Mind Medicine (MindMed) Inc. (MNMD) Q3 2024 Earnings Call Transcript
|
| Nov 7 |
Mind Medicine (MindMed) Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 7 |
Mind Medicine GAAP EPS of -$0.27 beats by $0.03
|
| Nov 7 |
MindMed Reports Third Quarter 2024 Financial Results and Business Updates
|
| Nov 6 |
Mind Medicine Q3 2024 Earnings Preview
|
| Nov 6 |
Massachusetts psychedelics legalization initiative poised to fail
|
| Nov 4 |
Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate
|
